Abeona Therapeutics Inc (NASDAQ:ABEO – Get Free Report) was the target of a large decrease in short interest in May. As of May 15th, there was short interest totalling 3,020,000 shares, a decrease of 9.9% from the April 30th total of 3,350,000 shares. Based on an average trading volume of 710,000 shares, the days-to-cover ratio […]
Abeona Therapeutics (NASDAQ:ABEO – Get Free Report) had its price objective decreased by equities research analysts at Cantor Fitzgerald from $28.00 to $21.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The brokerage currently has an “overweight” rating on the biopharmaceutical company’s stock. Cantor Fitzgerald’s price objective points to a […]
StockNews.com cut shares of Abeona Therapeutics (NASDAQ:ABEO – Free Report) from a hold rating to a sell rating in a research report sent to investors on Tuesday morning. Abeona Therapeutics Price Performance NASDAQ ABEO opened at $3.26 on Tuesday. Abeona Therapeutics has a fifty-two week low of $2.83 and a fifty-two week high of $9.01. […]
Abeona Therapeutics (NASDAQ:ABEO) Rating Reiterated by Cantor Fitzgerald theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Abeona Therapeutics Inc (NASDAQ:ABEO – Get Free Report) CFO Joseph Walter Vazzano purchased 5,608 shares of Abeona Therapeutics stock in a transaction dated Thursday, April 25th. The shares were purchased at an average cost of $3.14 per share, for a total transaction of $17,609.12. Following the transaction, the chief financial officer now owns 233,868 shares […]